Delay in diagnosis of breast cancer

被引:48
作者
Tartter, PI
Pace, D
Frost, M
Bernstein, JL
机构
[1] Mt Sinai Med Ctr, Breast Serv, Dept Surg, New York, NY 10029 USA
[2] Mt Sinai Med Ctr, Dept Community Med, New York, NY 10029 USA
关键词
D O I
10.1097/00000658-199901000-00012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives To assess the consequences of physician delay in the diagnosis of breast cancer by comparing stage, treatment, and outcome of patients with and without delay, and to identify patient characteristics that may make diagnosis more difficult. Summary Background Information Delay in diagnosis of breast cancer is the most common clinical scenario resulting in malpractice litigation. Methods The records of 1014 patients were reviewed and the events preceding the diagnosis were reconstructed. Accurate assessment of the physician delay in diagnosis could be made for 606 patients, 51 (8%) with physician delay >3 months. Patients with delay were comparable to patients without delay in terms of age, height, weight, age at menarche, pregnancies, children, proportion in menopause, age at menopause, and family history of breast cancer. Results Thirty-six percent of patients who had a delay in diagnosis had normal mammograms versus 7% of patients without delay. Cancers in patients with delay were significantly larger on average than in those without delay, but there were no significant differences in pathology, differentiation, nodal status, TNM stage, treatment, or outcome. Conclusions Physician delay in the diagnosis of breast cancer is common, and patients with delay are similar to patients without delay, although they are more likely to have normal mammograms. The consequences of physician delay in terms of stage at diagnosis, treatment, and outcome were not statistically significant.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 20 条
[1]   PATIENTS AND DOCTORS DELAY IN PRIMARY BREAST-CANCER - PROGNOSTIC IMPLICATIONS [J].
AFZELIUS, P ;
ZEDELER, K ;
SOMMER, H ;
MOURIDSEN, HT ;
BLICHERTTOFT, M .
ACTA ONCOLOGICA, 1994, 33 (04) :345-351
[2]  
CHARLSON ME, 1985, SURG GYNECOL OBSTET, V160, P393
[3]   Medicolegal aspects of breast cancer in US federal medical facilities: Analysis of 80 claims [J].
Chew, FS ;
OReilly, MAR ;
Schuckenbrock, CM ;
RelyeaChew, A ;
Foley, HT ;
OReilly, PMR .
MILITARY MEDICINE, 1996, 161 (06) :329-333
[4]  
Colton T, 1974, STAT MED
[5]  
CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7
[6]  
DENNIS CR, 1975, CANCER-AM CANCER SOC, V35, P714, DOI 10.1002/1097-0142(197503)35:3<714::AID-CNCR2820350326>3.0.CO
[7]  
2-V
[8]  
DOHRMANN PJ, 1982, SURG GYNECOL OBSTET, V154, P707
[9]  
FISHER ER, 1977, CANCER-AM CANCER SOC, V40, P3160, DOI 10.1002/1097-0142(197712)40:6<3160::AID-CNCR2820400661>3.0.CO
[10]  
2-P